Category: NuvasiveSyndicate content

Temporary tax hit pushes NuVasive into Q3 red

October 31, 2014 by Brad Perriello

NuVasive swings to a 3rd-quarter loss on higher-than-expected taxes, but beats Wall Street's sales expectations and says it expects to recoup the loss next quarter.

Temporary tax hit pushes NuVasive into Q3 red

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

BSX loses $309M judgment in patent war with the family of Dr. Michel Mirowski | Medtech legal news for the week of September 29, 2014

September 29, 2014 by MassDevice

Here's a look at some of the top legal news stories for medical device companies this week: Boston Scientific loses $309 million judgment in Mirowski patent war; Ex-Advanced Medical Optics CEO Mazzo indicted in insider trading case; Appeals court denies BD bid to revisit loss to Retractable Technologies; Ackman threatens to sue Allergan again over potential Salix deal; Judge upholds $30M infringement ruling against NuVasive, cancels trademark

Boston Scientific loses $309 million judgment in Mirowski patent war

September 24, 2014 by Brad Perriello

Judge upholds $30M infringement ruling against NuVasive, cancels trademark

September 25, 2014 by Brad Perriello

A federal judge in California upholds a $30 million trademark infringement judgment against NuVasive and revokes its registrations for the 'neurovision' name.

Judge upholds $30M infringement ruling against NuVasive, cancels trademark

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

NuVasive Forever Barred From Using NEUROVISION Trademark

Los Angeles, September 5, 2014 – A Los Angeles federal judge issued a permanent injunction earlier this week against NuVasive, Inc. (NUVA), forever barring the medical device manufacturer from using the trademark NEUROVISION to promote or sell medical devices in the United States.

HeartWare nabs JenaValve exec Leadley for medical chief | Personnel Moves

August 12, 2014 by Brad Perriello

HeartWare International names Dr. Katrin Leadley to be its new chief medical officer following the retirement of Dr. David Hathaway.

HeartWare nabs JenaValve exec Leadley for medical chief | Personnel Moves

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Judge denies NuVasive in NeuroVision spat, cancels trademark

August 11, 2014 by Brad Perriello

A federal judge denies NuVasive's bid to overturn a $30 million trademark infringement loss and cancels its trademark on the NeuroVision name.

Judge denies NuVasive in NeuroVision spat, cancels trademark

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

NuVasive soars on Q2 sales, earnings beats

July 30, 2014 by Brad Perriello

NuVasive shares surge more than 10% as the medical device company raises its outlook for the rest of the year after posting 2nd-quarter sales and earnings numbers that beat estimates.

NuVasive soars on Q2 sales, earnings beats

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp